NIHR HealthTech Research Centre (HRC) in Diagnostic and Technology Evaluation (DTE)

The NIHR HRC DTE applies innovative clinical research methods to efficiently evaluate new diagnostic technologies. Through supporting funding applications, working in partnership on projects, and delivering training, the NIHR HRC DTE help diagnostic innovators to develop their technologies and conduct their research from conceptualisation to potential adoption.

About NIHR HealthTech Research Centre in Diagnostic and Technology Evaluation

The NIHR HRC DTE applies innovative clinical research methods to efficiently evaluate new diagnostic technologies. This includes new diagnostic tests and devices, such as technologies related to imaging, artificial intelligence, and digital healthcare.

Hosted by the Newcastle upon Tyne Hospitals NHS Foundation Trust in partnership with Newcastle University, the centre specialises in evaluating diagnostics across three core clinical themes:

Ageing and Multiple Long-Term Conditions
Infection
Precision Medicine and Rare Diseases

The NIHR HRC DTE can offer Newcastle University researchers carrying out translational research:

advice and expertise in robust qualitative, statistical and health economic methods
help with building a multi-disciplinary team that will work collaboratively with you to ensure you generate the evidence you need
access to the Diagnostics North East network who can help diagnostic developers with every stage of their research from test idea to implementation and adoption

Stage

Researchers should approach the NIHR HRC DTE as soon as possible when they have an early translational idea and are looking for support.

If you plan to submit a grant application, the NIHR HRC DTE can support you and be a part of that application either as a co-applicant, collaborator or sub-contractor.

We support stages D3 and T1-T2 along the Translational Research Pathway. We also provide support with the development of intervention, pilot clinical evaluation and experimental medicine, as well as clinical evaluation and regulatory approval.

Contact